Literature DB >> 15502402

Inhibition mechanism of Gosha-jinki-gan on the micturition reflex in rats.

Akinobu Gotoh1, Kazuhiro Goto, Atsushi Sengoku, Toshiro Shirakawa, Yoshinobu Akao, Masato Fujisawa, Hiroshi Okada, Soichi Arakawa, Sadao Kamidono.   

Abstract

We investigated the actions of Gosha-jinki-gan, a traditional Japanese medicine containing processed Aconiti tubers, on urinary bladder function in anesthetized rats. In cystometrical investigations, Gosha-jinki-gan (1.0 g/kg, i.d.) increased bladder capacity as well as micturition threshold pressure. In addition, it decreased the frequency of distension-induced rhythmic bladder contractions. However, it did not influence the amplitude of bladder contractions induced by electrical stimulation of the pontine micturition center. The inhibitory effect of Gosha-jinki-gan on bladder motility was abolished by pretreatment with nor-binaltorphimine (10 mg/kg, s.c.), and was diminished by the concomitant use of anti-dynorphin A antiserum (10 microg, i.t.), yohimbine (10 microg, i.t.), or methysergide (20 microg, i.t.). Processed Aconiti tuber extract (27 mg/kg, i.d.) also suppressed bladder motility, and the effect was abolished by nor-binaltorphimine. These results suggest that Gosha-jinki-gan attenuates bladder sensation via the kappa-opioid receptor-stimulating action of processed Aconiti tuber. Gosha-jinki-gan may be a useful anti-pollakiuria agent that does not influence bladder contractility at micturition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502402     DOI: 10.1254/jphs.fpj03098x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  7 in total

1.  The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen.

Authors:  Masanori Nishioka; Mitsuo Shimada; Nobuhiro Kurita; Takashi Iwata; Shinya Morimoto; Kozo Yoshikawa; Jun Higashijima; Tomohiko Miyatani; Toru Kono
Journal:  Int J Clin Oncol       Date:  2011-01-22       Impact factor: 3.402

2.  Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

Authors:  Toru Kono; Taishi Hata; Satoshi Morita; Yoshinori Munemoto; Takanori Matsui; Hiroshi Kojima; Hiroyoshi Takemoto; Mutsumi Fukunaga; Naoki Nagata; Mitsuo Shimada; Junichi Sakamoto; Hideyuki Mishima
Journal:  Cancer Chemother Pharmacol       Date:  2013-12       Impact factor: 3.333

3.  Ignavine: a novel allosteric modulator of the μ opioid receptor.

Authors:  Katsuya Ohbuchi; Chika Miyagi; Yasuyuki Suzuki; Yasuharu Mizuhara; Keita Mizuno; Yuji Omiya; Masahiro Yamamoto; Eiji Warabi; Yuka Sudo; Akinobu Yokoyama; Kanako Miyano; Takatsugu Hirokawa; Yasuhito Uezono
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

4.  Clinical efficacy and tolerability of Gosha-jinki-gan, a Japanese traditional herbal medicine, for nocturia.

Authors:  Hiroshi Yagi; Kojiro Nishio; Ryo Sato; Gaku Arai; Shigehiro Soh; Hiroshi Okada
Journal:  J Tradit Complement Med       Date:  2015-01-30

5.  Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer.

Authors:  Toru Kono; Noriaki Mamiya; Naoyuki Chisato; Yosiaki Ebisawa; Hirotaka Yamazaki; Jiro Watari; Yasuhiro Yamamoto; Shigetaka Suzuki; Toshiyuki Asama; Kazunori Kamiya
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-11       Impact factor: 2.629

6.  Clinical efficacy and tolerability of two Japanese traditional herbal medicines, Hachimi-jio-gan and Gosha-jinki-gan, for lower urinary tract symptoms with cold sensitivity.

Authors:  Hiroshi Yagi; Ryo Sato; Kojiro Nishio; Gaku Arai; Shigehiro Soh; Hiroshi Okada
Journal:  J Tradit Complement Med       Date:  2015-04-18

7.  Evaluation of the efficacy of Chinese herbal medicine and acupuncture for the prevention of mental disorders in interstitial cystitis patients: A nationwide population-based study.

Authors:  Hao-Hsiu Hung; Wen-Chi Chen; Yung-Hsiang Chen; Lu-Ting Chiu; Huey-Yi Chen
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.